combined BRAF-MEK inhibitors | KRAS gene alteration targeted therapy | MET gene alteration targeted therapy | NTRK gene alteration targeted therapy | RET gene alteration targeted therapy | |||
trametinib plus dabrafenib | sotorasib | capmatinib | entrectinib | larotrectinib | pralsetinib | selpercatinib |